Taken together, we can carefully conclude that NAOs can suppress obesity and related metabolic syndromes (hyperlipidemia and pre-diabetic symptoms) by enhancing adiponectin concentration in blood, which should be further validated. The gene discussed is ADIPOQ; the disease is hyperlipidemia.